Previous studies have shown that in ER+ breast cancer cells E2 stimulates migration through activation of mitogen-activated protein kinase (MAPK) phosphorylation of cSRC, which in turn interacts with focal adhesion kinases and the delta 5 truncated form of SRC3. Here, WNK2 is linked to breast carcinoma.